Suppr超能文献

耳鼻喉科中的细胞抑制疗法(作者译)

[Cytostatic therapy in oto-rhino-laryngology (author's transl)].

作者信息

Neumann H, Wicke W

出版信息

Laryngol Rhinol Otol (Stuttg). 1976 Dec;55(12):976-9.

PMID:138039
Abstract

The report covers the therapeutic results achieved after using cytostatic drugs in 104 patients treated at the 1st Oto-Rhino-Laryngological Univ. Hospital, Vienna, between 1967 and 1975. The breakdown according to the tumor histology shows that squamous cell carcinomas accounted for the highest per centage, i.e. 53%; laryngeal tumor prevails according to the tumor localization. In 42 patients it was not possible to positively influence the disease; 45 patients showed a disruption or a slowdown of the progress of the disease; in 17 patients all measurable criteria of the disease receded (classification according to Karnofsky). Even if the average survival time after the commencement of the therapy amounted to only about 6 months, it was nevertheless possible to positively influence the progress of the disease by means of cytosatic therapy.

摘要

该报告涵盖了1967年至1975年间在维也纳第一耳鼻喉科大学医院接受治疗的104例使用细胞抑制药物后的治疗结果。根据肿瘤组织学分类显示,鳞状细胞癌占比最高,即53%;根据肿瘤定位,喉肿瘤最为常见。42例患者的病情未能得到积极改善;45例患者的病情发展出现中断或减缓;17例患者的所有可测量疾病标准均有所缓解(根据卡诺夫斯基分类)。尽管治疗开始后的平均生存时间仅约为6个月,但通过细胞抑制疗法仍有可能对疾病进展产生积极影响。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验